Question

A client is receiving IV paclitaxel for treatment of ovarian cancer. Which of the following assessment data is a priority concern?
A. Bleeding gums, unexplained bruising
B. Hair loss occurring 8 days after beginning treatmentIncrease in fatigue
C. Client complains of chest pain and shortness of breath

Answer 1

Answer:

B. Hair loss occurring 8 days after beginning treatment Increase in fatigue

Explanation:

Answer 2

Answer:

C. Client complains of chest pain and shortness of breath

Explanation:

Paclitaxel is indicated as the first and second line of treatment for advanced ovarian carcinoma. When indicated as the first line of treatment, paclitaxel is used in combination with another platinum compound medicine.

This medicine can only be used with medical supervision and it is important that the medical team pay attention if during treatment the patient has chest pain and / or shortness of breath because this indicates that the patient is suffering from an allergic reaction and the medicine should be stopped and exchanged.